TS

Tammu Shree

Active Director Director DIN 10549641
DIN 10549641 First appointment Mar 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2024
Shareholding value Locked Premium profile

About Tammu Shree

Tammu Shree has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Ortis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10549641
Primary Designation Director
First Appointment 18 Mar 2024
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Ortis Pharma Private Limited U24299UP2021PTC150293
Director 18 Mar 2024 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ortis Pharma Private Limited
Premium access

Shareholding and investment profile for Tammu Shree

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tammu Shree

Tammu Shree has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Ortis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Tammu Shree is associated with 1 company as Director.

Tammu Shree has expertise in General Business.

Tammu Shree has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available